Stocktoria
Eloxx Pharmaceuticals, Inc. ELOX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-11-23
Eloxx Pharmaceuticals, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Domicilium Real Estate Fund III LP | 10% owner | 2026-06-10 | J | 238,422 | — |
| Domicilium Real Estate Fund III LP | 10% owner | 2026-06-10 | J | 361,578 | — |
| Domicilium Real Estate Fund III LP | 10% owner | 2026-05-27 | J | 113,636 | — |
| Coastlands Capital LP | 10% owner | 2026-05-27 | J | 1,250,000 | — |
| Aggarwal Sumit | President and CEO | 2026-02-28 | Option exercise | 260,946 | $0.15 |
| Aggarwal Sumit | President and CEO | 2026-01-24 | Option exercise | 15,000 | — |
| Rubin Steven D | director | 2026-01-24 | Option exercise | 1,875 | — |
| Aggarwal Sumit | President and CEO | 2025-09-19 | Grant | 1,000,000 | — |
Source: SEC EDGAR filings · CIK 0001035354 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.